Christina Hanzis

481 total citations
25 papers, 292 citations indexed

About

Christina Hanzis is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Christina Hanzis has authored 25 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 12 papers in Pathology and Forensic Medicine and 10 papers in Immunology. Recurrent topics in Christina Hanzis's work include Chronic Lymphocytic Leukemia Research (24 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). Christina Hanzis is often cited by papers focused on Chronic Lymphocytic Leukemia Research (24 papers), Lymphoma Diagnosis and Treatment (10 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). Christina Hanzis collaborates with scholars based in United States. Christina Hanzis's co-authors include Christopher J. Patterson, Patricia Sheehy, Robert Manning, Steven P. Treon, Leukothea Ioakimidis, Zachary R. Hunter, Christina Tripsas, Barry Turnbull, Guang Yang and Lian Xu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and British Journal of Haematology.

In The Last Decade

Christina Hanzis

25 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christina Hanzis United States	8	270	214	118	92	25	25	292
Antonino Greco Italy	3	236 0.9×	218 1.0×	124 1.1×	68 0.7×	14 0.6×	10	293
Nickolas Tsakmaklis United States	7	304 1.1×	274 1.3×	176 1.5×	96 1.0×	12 0.5×	34	363
Fabrizio Luciano Italy	5	245 0.9×	190 0.9×	136 1.2×	41 0.4×	3 0.1×	11	290
Olivier Theisen France	6	163 0.6×	145 0.7×	84 0.7×	71 0.8×	11 0.4×	18	246
Paulino Fernández-Navarro Spain	7	236 0.9×	197 0.9×	171 1.4×	45 0.5×	12 0.5×	7	266
Rosa Fisac Spain	8	84 0.3×	61 0.3×	63 0.5×	63 0.7×	15 0.6×	12	193
Geisler Ch Denmark	5	357 1.3×	291 1.4×	186 1.6×	73 0.8×	4 0.2×	6	388
Chiara Lobetti Bodoni Italy	6	105 0.4×	116 0.5×	47 0.4×	25 0.3×	2 0.1×	8	194
J. Maciejewski United States	7	107 0.4×	30 0.1×	34 0.3×	259 2.8×	16 0.6×	10	345
Iryna Kryachok Ukraine	8	127 0.5×	123 0.6×	70 0.6×	36 0.4×	1 0.0×	23	197

Countries citing papers authored by Christina Hanzis

Since Specialization

Citations

This map shows the geographic impact of Christina Hanzis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christina Hanzis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christina Hanzis more than expected).

Fields of papers citing papers by Christina Hanzis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christina Hanzis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christina Hanzis. The network helps show where Christina Hanzis may publish in the future.

Co-authorship network of co-authors of Christina Hanzis

This figure shows the co-authorship network connecting the top 25 collaborators of Christina Hanzis. A scholar is included among the top collaborators of Christina Hanzis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christina Hanzis. Christina Hanzis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Treon, Steven P., Christina Tripsas, Christina Hanzis, et al.. (2012). Familial Disease Predisposition Impacts Treatment Outcome in Patients With Waldenström Macroglobulinemia. Clinical Lymphoma Myeloma & Leukemia. 12(6). 433–437. 22 indexed citations

Philpot, Lindsey M., Rohit P. Ojha, Martha Felini, et al.. (2011). Site-specific relative risks of second primary malignancies among patients with Waldenstrom macroglobulinemia.. Journal of Clinical Oncology. 29(15_suppl). e18566–e18566. 1 indexed citations

Treon, Steven P., Christina Hanzis, Robert Manning, et al.. (2011). Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab‐containing regimen. British Journal of Haematology. 154(3). 357–362. 60 indexed citations

Ciccarelli, Bryan, Christopher J. Patterson, Zachary R. Hunter, et al.. (2011). Hepcidin Is Produced by Lymphoplasmacytic Cells and Is Associated With Anemia in Waldenström's Macroglobulinemia. Clinical Lymphoma Myeloma & Leukemia. 11(1). 160–163. 22 indexed citations

Ojha, Rohit P., Christina Hanzis, Zachary R. Hunter, et al.. (2011). Family history of non-hematologic cancers among Waldenstrom macroglobulinemia patients: A preliminary study. Cancer Epidemiology. 36(3). 294–297. 4 indexed citations

Treon, Steven P., Christina Hanzis, Christina Tripsas, et al.. (2011). Bendamustine Therapy in Patients With Relapsed or Refractory Waldenström's Macroglobulinemia. Clinical Lymphoma Myeloma & Leukemia. 11(1). 133–135. 65 indexed citations

Hanzis, Christina, Rohit P. Ojha, Zachary R. Hunter, et al.. (2011). Associated Malignancies in Patients with Waldenström's Macroglobulinemia and Their Kin. Clinical Lymphoma Myeloma & Leukemia. 11(1). 88–92. 28 indexed citations

Hunter, Zachary R., Lian Xu, Yangsheng Zhou, et al.. (2011). Whole-Genome Sequencing Results From 30 Patients with Waldenstrom's Macroglobulinemia. Blood. 118(21). 434–434. 6 indexed citations

Treon, Steven P., Zachary R. Hunter, Christina Hanzis, et al.. (2011). Treatment with a Bortezomib-Containing Regimen Is Associated with Better Therapeutic Outcomes in Patients with Waldenstrom's Macroglobulinemia Who Have Familial Disease Predisposition. Blood. 118(21). 1643–1643. 1 indexed citations

10.

Hunter, Zachary R., Yang Cao, Jenny Sun, et al.. (2010). Aberrant Expression of Regulatory miRNAs and Transcripts for IRS-PI3K Growth and Survival Signaling In Waldenstrom's Macroglobulinemia. Blood. 116(21). 1912–1912. 2 indexed citations

11.

Yang, Guang, Lian Xu, Zachary R. Hunter, et al.. (2010). The Rituximab and IVIG Related IgM Flare In Waldenstrom's Macroglobulinemia Is Associated with Monocytic Activation of Fcgriia Signaling, and Triggering of IL-6 Release by the PI3K/AKT and MAPK Pathways. Blood. 116(21). 2870–2870. 7 indexed citations

12.

Yang, Guang, Christina Hanzis, Sigitas Verselis, et al.. (2010). The Anti-CD20 Monoclonal Antibody GA101 Displays More Robust Anti-Tumor Activity Versus Rituximab In Waldenstrom's Macroglobulinemia (WM). Blood. 116(21). 4904–4904. 2 indexed citations

13.

Ciccarelli, Bryan, Zachary R. Hunter, Christina Hanzis, et al.. (2010). Comprehensive Assessment of Cytokines and Chemokines In Patients with Waldenstrom's Macroglobulinemia Reveals a Distinct Profile with Pathobiological and Clinical Relevance. Blood. 116(21). 1911–1911. 2 indexed citations

14.

Treon, Steven P., Christina Hanzis, Leukothea Ioakimidis, et al.. (2010). Clinical characteristics and treatment outcome of disease-related peripheral neuropathy in Waldenstrom's macroglobulinemia (WM).. Journal of Clinical Oncology. 28(15_suppl). 8114–8114. 8 indexed citations

15.

Hunter, Zachary R., Robert Manning, Christina Hanzis, et al.. (2009). IgA and IgG hypogammaglobulinemia in Waldenstrom's macroglobulinemia. Haematologica. 95(3). 470–475. 30 indexed citations

16.

Ciccarelli, Bryan, Christopher J. Patterson, Zachary R. Hunter, et al.. (2009). Patients with Waldenstrom's Macroglobulinemia Are Often Hypoferremic That Is Refractory to Oral Iron Repletion and Responsive to Parental Iron Infusions, and Demonstrate Elevated Levels of Hepcidin.. Blood. 114(22). 2952–2952. 2 indexed citations

17.

Treon, Steven P., Christina Hanzis, Christopher J. Patterson, et al.. (2009). Maintenance Rituximab Is Associated with Improved Progression Free and Overall Survival in Waldenstrom's Macroglobulinemia.. Blood. 114(22). 3750–3750. 1 indexed citations

18.

Yang, Guang, Lian Xu, Zachary R. Hunter, et al.. (2009). The IgM Flare Following Rituximab and IVIG Administration in Waldenstrom's Macroglobulinemia Is Related to IL-6 Production by Bystander Immune Cells, Possibly through Stimulation of the Fcgriia Receptor.. Blood. 114(22). 761–761. 7 indexed citations

19.

Yang, Guang, Lian Xu, Zachary R. Hunter, et al.. (2009). The Inhibitory Receptor FcgRIIB Is Overexpressed, and Its Ligation by Anti- FcgRIIB Antibodies Suppresses IgM Production and Induces Apoptosis in Waldenstrom's Macroglobulinemia.. Blood. 114(22). 3736–3736. 1 indexed citations

20.

Treon, Steven P., Zachary R. Hunter, Bryan Ciccarelli, et al.. (2008). IgA and IgG Hypogammaglobulinemia Is a Constitutive Feature in Most Waldenstrom’s Macroglobulinemia Patients and May Be Related to Mutations Associated with Common Variable Immunodeficiency Disorder (CVID). Blood. 112(11). 3749–3749. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact